Women more depressed and men more impulsive with reduced serotonin functioningSeptember 18, 2007Women and men appear to respond differently to the same biochemical manipulation. Major depressive disorder (MDD) is one of the most common mental disorders, and it is also one of the most studied. It is already known that reduced serotonin transmission contributes to the pathophysiology, or functional changes, associated with MDD and most of today's most popular antidepressants block the serotonin "uptake site", also known as the transporter, in the brain. It is also known that people with MDD are frequently found to have impaired impulse control. A new study being published in the September 15th issue of Biological Psychiatry now reports on important sex and genetic differences in the way that men and women react to reductions in serotonin function, specifically in terms of their mood and impulsivity. Using a technique in healthy participants called acute tryptophan depletion, which decreases serotonin levels in the brain, Walderhaug and colleagues found that men became more impulsive, but did not experience any mood changes in response to the induced chemical changes. However, women in this study reported a worsening of their mood and they became more cautious, a response commonly associated with depression. The researchers also discovered that the mood lowering effect in women was influenced by variation in the promotor region of the serotonin transporter gene (5-HTTLPR). One of the study's authors, Dr. Espen Walderhaug, explains, "We were surprised to find such a clear sex difference, as men and women normally experience the same effect when the brain chemistry is changed- Although we have the same serotonergic system in the brain, it is possible that men and women utilize serotonin differently."
These findings highlight the complexity of studying and treating these disorders, as the interactive effects of gender and genetic coding impacted the outcomes in the men and women when their serotonergic functions were disrupted. Dr. Walderhaug comments that their study's findings "might be relevant in understanding why women show a higher prevalence of mood and anxiety disorders compared to men, while men show a higher prevalence of alcoholism, ADHD and impulse control disorders." John H. Krystal, M.D., Editor of Biological Psychiatry and affiliated with both Yale University School of Medicine and the VA Connecticut Healthcare System, adds that the response patterns that have emerged in these findings are "the beginnings of an understanding for these sex-related effects." Ultimately, it is hoped that these findings further advance the ability to quickly and more accurately treat patients. Elsevier | |||||||||||||||||||||
|
Related Serotonin News Articles The first autism disease genes The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'. PET scans help identify mechanism underlying seasonal mood changes Brain scans taken at different times of year suggest that the actions of the serotonin transporter-involved in regulating the mood-altering neurotransmitter serotonin-vary by season, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Post-marketing studies finding adverse events in drugs used in children The Food and Drug Administration Modernization Act (FDAMA, 1997), designed to stimulate more drug safety studies in children, has resulted in more than 130 label changes since its inception nearly six years ago, according to researchers at Duke Children's Hospital. Sex differences seen in response to common antidepressant Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms. Antidepressants in suicide prevention Antidepressants are the cornerstone of treatment of depressive disorders in health care. Their efficacy in treating depression is undisputable, although it leaves room for improvement. UNC trial: oral contraceptives may ease suffering of women with severe PMS A new clinical trial at the University of North Carolina at Chapel Hill using a popular low-dose contraceptive could uncover a more effective treatment for the 5 to 10 percent of women who suffer from premenstrual dysphoric disorder (PMDD). Voluntary exercise does not appear to alleviate anxiety and depression Voluntary physical activity does not appear to cause a reduction in anxiety and depression, but exercise and mood may be associated through a common genetic factor, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Use of sildenafil associated with improvement in antidepressant-related sexual dysfunction in women Women with sexual dysfunction caused by the use of antidepressants experienced a reduction in adverse sexual effects with use of sildenafil, commonly known as the erectile dysfunction medication Viagra. Some antidepressants associated with gastrointestinal bleeding A class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) appear to be associated with bleeding in the upper gastrointestinal tract. UCLA researchers clarify function of glucose transport molecule Researchers at the David Geffen School of Medicine at UCLA have solved the structure of a class of proteins known as sodium glucose co-transporters (SGLTs), which pump glucose into cells. More Serotonin News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||